These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 29128343)

  • 21. Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta-Analysis.
    Cui M; Huang CY; Wang F
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2905-2918. PubMed ID: 30201459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of Paroxetine for Poststroke Depression: A Meta-Analysis.
    Li L; Han Z; Li L; Han L; Yan B
    J Stroke Cerebrovasc Dis; 2020 May; 29(5):104664. PubMed ID: 32093988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined In Silico, Ex Vivo, and In Vivo Assessment of L-17, a Thiadiazine Derivative with Putative Neuro- and Cardioprotective and Antidepressant Effects.
    Sarapultsev A; Vassiliev P; Grinchii D; Kiss A; Mach M; Osacka J; Balloova A; Paliokha R; Kochetkov A; Sidorova L; Sarapultsev P; Chupakhin O; Rantsev M; Spasov A; Dremencov E
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating the Potential Mechanisms and Therapeutic Targets of Inflammatory Cytokines in Post-stroke Depression.
    Zhang Y; Yang Y; Li H; Feng Q; Ge W; Xu X
    Mol Neurobiol; 2024 Jan; 61(1):132-147. PubMed ID: 37592185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensive overview of post-stroke depression treatment options.
    Raggi A; Serretti A; Ferri R
    Int Clin Psychopharmacol; 2024 May; 39(3):127-138. PubMed ID: 38170802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective serotonin reuptake inhibitors for stroke recovery.
    Mead GE; Hsieh CF; Hackett M
    JAMA; 2013 Sep; 310(10):1066-7. PubMed ID: 24026602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic differences among the SSRIs: focus on monoamine transporters and the HPA axis.
    Nemeroff CB; Owens MJ
    CNS Spectr; 2004 Jun; 9(6 Suppl 4):23-31. PubMed ID: 15181382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression.
    Kimura M; Kanetani K; Imai R; Suzuki H; Isayama K; Endo S
    Int Clin Psychopharmacol; 2002 May; 17(3):121-5. PubMed ID: 11981353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms associated with post-stroke depression and pharmacologic therapy.
    Zhan Q; Kong F
    Front Neurol; 2023; 14():1274709. PubMed ID: 38020612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Post-stroke depression].
    Levada OA; Slivko EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():73-9. PubMed ID: 18196638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives.
    Turner-Stokes L; Hassan N
    Clin Rehabil; 2002 May; 16(3):248-60. PubMed ID: 12017512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-stroke depression: A 2020 updated review.
    Medeiros GC; Roy D; Kontos N; Beach SR
    Gen Hosp Psychiatry; 2020; 66():70-80. PubMed ID: 32717644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Post-stroke depression (II): its differential diagnosis, complications and treatment].
    Carod-Artal FJ
    Rev Neurol; 2006 Feb 16-28; 42(4):238-44. PubMed ID: 16521063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-stroke depression: Chaos to exposition.
    Sarkar A; Sarmah D; Datta A; Kaur H; Jagtap P; Raut S; Shah B; Singh U; Baidya F; Bohra M; Kalia K; Borah A; Wang X; Dave KR; Yavagal DR; Bhattacharya P
    Brain Res Bull; 2021 Mar; 168():74-88. PubMed ID: 33359639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.
    Vaswani M; Linda FK; Ramesh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):85-102. PubMed ID: 12551730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural Products for the Treatment of Post-stroke Depression.
    Fang C; Zhang Z; Xu H; Liu Y; Wang X; Yuan L; Xu Y; Zhu Z; Zhang A; Shao A; Lou M
    Front Pharmacol; 2022; 13():918531. PubMed ID: 35712727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Post-stroke depression: recognition and treatment interventions].
    Arseniou S; Arvaniti A; Samakouri M
    Psychiatriki; 2011; 22(3):240-8. PubMed ID: 21971199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.